Free
See the whole market and how each asset scores.
- Full searchable catalog — all 858 assets
- Per-asset PoS, letter grade & data confidence
- Score methodology & top drivers
- Full score methodology on every asset
Pricing
Deal-flow intelligence pharma keeps missing.
License-Rx scores 858 university- and NIH-originated technologies on a transparent probability-of-success model, then hands your BD team the buyers, the cheapest decisive experiment, and the fastest partnerable milestone. Built for pharma/biotech business development and life-science founders.
Most popular
$1,000/month
The full BD workbench for teams sourcing licensable IP.
- Everything in Scout
- Unlimited strategic deep dives
- Buyer map, roadmap & cheapest decisive experiment
- Shortlists + CSV / PDF export
- Pipeline Sync fit-ranking to your therapeutic focus
- New-asset & keyword alerts
- Source links & evidence trail per asset
Cancel anytime · billed monthly · annual available
Custom
For funds & corporate BD running this across a group.
- Everything in Operator
- Seats for the whole team
- Shared shortlists & saved searches
- Custom institution & catalog ingestion
- Priority support & onboarding
Why teams pay for it
One subscription replaces a diligence analyst's first pass.
Every asset arrives pre-scored and pre-argued: the odds, the biggest risk, the likely acquirer, and the one experiment that would de-risk it. Your team spends its time on the ten assets worth a call — not the 848 that aren't.
- Transparent PoS you can defend in an investment committee.
- Sub-factor breakdown so you see why, not just a number.
- From catalog listing to a partnerable thesis in one screen.
858assets scored across NIH, Penn & NYU
Questions BD teams ask
Where does the PoS score come from?
A transparent, weighted model over public catalog signals — data maturity, IP position, modality feasibility, indication pull, competitive whitespace, translational evidence, and licensing readiness — anchored to development-stage benchmarks. Every sub-factor and its rationale is shown. It's an estimate, not investment advice.
Is the data any different from a tech-transfer site?
The catalog starts from public listings; the value is the analysis layer on top — scoring, buyer mapping, and the fastest de-risking path — so you triage in minutes instead of reading PDFs.
Can my whole team use one account?
Operator is a single seat. For multiple BD users, shared shortlists, and custom ingestion, the Team plan adds seats and onboarding — talk to us below.
Can I cancel?
Yes, anytime, from your account. Your access continues to the end of the billing period.
Not ready to subscribe?
Book a 20-minute walkthrough.
We'll screen-share a live deep dive on an asset in your focus area.